Gastrointestinal Flashcards

1
Q

Examples of Antacids

A

Magnesium oxide, magnesium hydroxide, aluminum oxide and calcium carbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of antacids

A

buffers neutralize gastric acids and decrease pH-dependent conversion of pepsinogen to pepsin (increasing gastric pH to above 3.5 reduces proteolysis catalyzed by pepsin); reduces gastric damage to mucosal lining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Therapeutic effects of antacids

A

Reduces gastritis and peptic ulcer disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of antimicrobials and antibiotics

A

amoxicillin and/or tetracycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of bismuth

A

bismuth increases mucus secretion and disrupts bacterial cell wall adhesion to gastric mucosa, reduces bacterial damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of antibiotics in gastric pharmacology

A

antibiotics inhibit bacterial cell growth and eliminate infection by H. Pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Therapeutic effect of antimicrobials and antibiotics

A

to treat peptic ulcer disease, gastritis and H. Pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Examples of histamine receptor antagonists

A

cimetidine and rantidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of histamine receptor antagonists

A

parietal cell H2 histamine receptor antagonist; blocks activation of proton pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

therapeutic effect of histamine receptor antagonists

A

treatment of peptic ulcer disease, gastritis and GERD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

examples of proton pump inhibitors

A

omeprazole and esomeprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of proton pump inhibitors

A

drugs directly inhibit proton pump on parietal cells; slow onset of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

therapeutic effects of proton pump inhibitors

A

treatment of GERD, peptic ulcer disease, gastritis, esophagitis and esophageal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Examples of synthetic prostaglandins

A

misoprostol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA of synthetic prostaglandins

A

prostaglandin receptor agonist along GI tract; mimics the inhibitory effects of prostaglandins on parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

therapeutic effect of synthetic prostaglandins

A

treat gastritis, peptic ulcer disease caused by steroid and other drugs (NSAIDs)

17
Q

Example of anti-diarrheal agents

A

loperamide

18
Q

MOA of anti-diarrheal agents

A

opioid receptor agonist along GI tract; mimics inhibitory effects of endorphins

19
Q

therapeutic effects of anti-diarrheal

A

treating diarrhea

20
Q

examples of prokinetic medications

A

metoclopramide and erythromycin

21
Q

MOA of metoclopramide

A

a D2 receptor antagonist that suppresses the inhibitory effects of dopamine on cholinergic smooth muscle contractions along the GI tract.

22
Q

MOA of erythromycin

A

Erythromycin is a motilin receptor agonist that triggers smooth muscle contractions on the GI tract

23
Q

therapeutic effect of prokinetic medications, specifically metoclopramide

A

metoclopramide is used in the treatment of delayed gastric emptying due to diabetic gastroparesis and GERD.

24
Q

therapeutic effect of prokinetic medications, specifically erythromycin

A

Erythromycin is used before endoscopies for emptying

25
Q

Example of a human guanylin and uroguanylin agonist

A

linaclotide

26
Q

MOA of human guanylin and uroguanylin agonists

A

guanylin acts as an agonist of the guanylyl cyclase receptor that regulates electrolyte and water transport into the lumen of the intestine. Linacotide is a guanylin/guanylate cyclase-c agonist. Draws more water into the stool by bringing more sodium and bicarb into the lumen. Water follows.

27
Q

Therapeutic effect of linaclotide

A

Linaclotide is used in the treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

28
Q

things to consider to educate the patient when taking linaclotide

A

Linzess should be taken on an empty stomach at least 30 minutes before the first meal of the day. Taking linaclotide (Linzess) immediately after the high fat breakfast results in looser stools and a higher stool frequency compared with taking it in the fasted state.

29
Q

true or false: patients with cystic fibrosis do NOT have the cystic fibrosis transmembrane conductance regulator (CFTR)

A

true

30
Q

What are proton pumps?

A

Proton pumps are found in parietal cells. When stimulated by histamine 2 proton pumps will pump H+ into the stomach which will contribute to hydrochloric acid. When prostaglandins are present in a parietal cell, the proton pumps are turned off.

31
Q

What are gastric endocrine cells?

A

extrachromaffin-like cells that are located near parietal cells, contain receptors for gastrin and ACh that when activated trigger the release of histamine that then interacts with parietal cells.

32
Q

what pH does the gastric content need to be, to convert pepsinogen to pepsin?

A

less than 3.5

33
Q

what does pepsin break down?

A

proteins

34
Q

What neurotransmitter inhibits cholinergic control of peristalsis?

A

dopamine

35
Q

What hormone enhances gastric motility?

A

motilin

36
Q

Why should a pt not take metoclopramide for prolonged periods of time?

A

it may cause tardive dyskinesia d/t its persistent dopamine antagonistic effect

37
Q

MOA of dicyclomine (bentyl)

A

cholinergic receptor antagonist in the GI system; suppresses peristalsis and spasms

38
Q

Treatment of inflammatory bowel disease (could also be used for RA)

A

Infliximab; it is an IV infusion. Antibody to tumor necrosis factor. Immune system suppressant. Must test for latent TB before administering